期刊文献+

Combination of high-sensitivity C-reactive protein and homocysteine may predict an increased risk of coronary artery disease in Korean population 被引量:28

Combination of high-sensitivity C-reactive protein and homocysteine may predict an increased risk of coronary artery disease in Korean population
原文传递
导出
摘要 Background The association of emerging biomarkers such as high-sensitivity C-reactive protein (hs-CRP),homocysteine and fibrinogen with the risk of coronary artery disease (CAD) is still uncertain in Asian population including Koreans and little is known about the combined effect of biomarkers on the risk of CAD.Methods A total of 10 650 subjects (6538 men and 4112 women) were enrolled in this study.A 10-year CAD risk was calculated using Framingham risk score modified by the National Cholesterol Education Program (NCEP) Adult Treatment Panel Ⅲ (ATP Ⅲ ) and levels of circulating hs-CRP,homocysteine and fibrinogen were measured using validated assays.Results The 10-year CAD risk gradually augmented with increase in the circulating levels of hs-CRP,homocysteine and fibrinogen.For the highest quartile of hs-CRP,odds ratio (OR) of high-risk for CAD (10-year risk ≥20%) compared with the lowest quartile was 3.97 (95% C/:2.51-6.29).For homocysteine and fibrinogen,ORs in the highest quartile compared to the lowest quartile were 5.10 (95% Cl:3.05-8.53,P 〈0.001) and 1.46 (95% Cl:0.69-3.11,P=0.325),respectively.OR of high-risk for CAD in both the highest quartile of hs-CRP and homocysteine was 9.05 (95% CI:5.30-15.45) compared with the below median of hs-CRP and homocysteine.Conclusions The present study demonstrated that hs-CRP and homocysteine are well associated with the 10-year CAD risk estimated using NCEP ATP Ⅲ in Koreans and combination of hs-CRP and homocysteine can have strong synergyin predicting the development of CAD. Background The association of emerging biomarkers such as high-sensitivity C-reactive protein (hs-CRP),homocysteine and fibrinogen with the risk of coronary artery disease (CAD) is still uncertain in Asian population including Koreans and little is known about the combined effect of biomarkers on the risk of CAD.Methods A total of 10 650 subjects (6538 men and 4112 women) were enrolled in this study.A 10-year CAD risk was calculated using Framingham risk score modified by the National Cholesterol Education Program (NCEP) Adult Treatment Panel Ⅲ (ATP Ⅲ ) and levels of circulating hs-CRP,homocysteine and fibrinogen were measured using validated assays.Results The 10-year CAD risk gradually augmented with increase in the circulating levels of hs-CRP,homocysteine and fibrinogen.For the highest quartile of hs-CRP,odds ratio (OR) of high-risk for CAD (10-year risk ≥20%) compared with the lowest quartile was 3.97 (95% C/:2.51-6.29).For homocysteine and fibrinogen,ORs in the highest quartile compared to the lowest quartile were 5.10 (95% Cl:3.05-8.53,P 〈0.001) and 1.46 (95% Cl:0.69-3.11,P=0.325),respectively.OR of high-risk for CAD in both the highest quartile of hs-CRP and homocysteine was 9.05 (95% CI:5.30-15.45) compared with the below median of hs-CRP and homocysteine.Conclusions The present study demonstrated that hs-CRP and homocysteine are well associated with the 10-year CAD risk estimated using NCEP ATP Ⅲ in Koreans and combination of hs-CRP and homocysteine can have strong synergyin predicting the development of CAD.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2012年第4期569-573,共5页 中华医学杂志(英文版)
关键词 C-reactive protein HOMOCYSTEINE FIBRINOGEN coronary artery disease C-reactive protein homocysteine fibrinogen coronary artery disease
  • 相关文献

参考文献25

  • 1Cappuccio FP, Oakeshott P, Strazzullo P, Kerry SM.Application of Framingham risk estimates to ethnic minorities in United Kingdom and implications for primary prevention of heart disease in general practice:cross sectional population based study.BMJ 2002; 325:1271.
  • 2Talbert RL.New therapeutic options in the National Cholesterol Education Program Adult Treatment Panel Ⅲ .Am J Manag Care 2002; 8:S301-S307.
  • 3Pearson TA.New tools for coronary risk assessment:what are their advantages and limitations? Circulation 2002; 105:886-892.
  • 4Boekholdt SM,Hack CE,Sandhu MS,Luben R,Bingham SA,Wareham NJ,et al.C-reactive protein levels and coronary artery disease incidence and mortality in apparently healthy men and women:the EPIC-Norfolk prospectivepopulation study 1993-2003.Atherosclerosis 2006; 187:415-422.
  • 5Cushman M,Arnold AM,Psaty BM,Manolio TA,Kuller LH,Burke GL,et al.C-reactive protein and the 10-year incidence of coronary heart disease in older men and women:the cardiovascular health study.Circulation 2005; 112:25-31.
  • 6Lowe GD,Sweetnam PM,Yarnell JW,Rumley A,Rumley C,Bainton D,et al.C-reactive protein,fibrin D-dimer,and risk of ischemic heart disease:the Caerphilly and Speedwell studies.Arterioscler Thromb Vasc Bio12004; 24:1957-1962.
  • 7Tzoulaki I,Murray GD,Lee AJ,Rumley A,Lowe GD,Fowkes FG.Relative value of inflammatory,hemostatic,and theological factors for incident myocardial infarction and stroke:the Edinburgh Artery Study.Circulation 2007; 115:2119-2127.
  • 8Park CS,Ihm SH,Yoo KD,Kim DB,Lee JM,Kim HY,et al.Relation between C-reactive protein,homocysteine levels,fibrinogen,and lipoprotein levels and leukocyte and platelet counts,and 10-year risk for cardiovascular disease among healthy adults in the USA.Am J Cardiol 2010; 105:1284-1288.
  • 9Ballantyne CM,Hoogeveen RC,Bang H,Coresh J,Folsom AR,Heiss G,et al.Lipoprotein-associated phospholipase A2,high-sensitivity C-reactive protein,and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.Circulation 2004; 109:837-842.
  • 10Helfand M,Buckley DI,Freeman M,Fu R,Rogers K,Fleming C,et al.Emerging risk factors for coronary heart disease:a summary of systematic reviews conducted for the U.S.Preventive Services Task Force.Ann Intern Med 2009;151:496-507.

同被引文献148

引证文献28

二级引证文献265

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部